Lemann, M [What can be expected from biological therapies for Crohn's disease?]. [electronic resource] - Gastroenterologie clinique et biologique Nov 2001 - 945-7 p. digital Publication Type: Comment; Editorial; Review ISSN: 0399-8320 Subjects--Topical Terms: Antibodies, Monoclonal--adverse effectsAnus Diseases--drug therapyCrohn Disease--complicationsGastrointestinal Agents--adverse effectsHumansInfliximabTumor Necrosis Factor-alpha--immunology